Per the Johns Hopkins study - "There is no sing
Post# of 148161
"There is no single, effective treatment."
- would it not make sense to grant an EUA for a drug with no SAE's for 7 years on the most immunocompromised of all (AIDS patients), a drug that showed it helped mitigate 18 of 24 longhaulers symptoms?
Is this not a reasonable expectation of a public health agency?
Can the FDA/CDC/NIH get ANYTHING right???
Rhetorical question only.